COMMUNIQUÉS West-GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast
14/11/2018
CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]
RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium
14/11/2018
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Canntab Corporate Update
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited ( CSE: PILL , FSE: TBF1) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid oral dosage formulation of [...]
MacroGenics Announces Poster Presentation on Preclinical PD-L1 x CD137 DART® Program at the EORTC-NCI-AACR Symposium in Dublin
14/11/2018
ROCKVILLE, MD, Nov. 14, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
14/11/2018
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer [...]
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights
14/11/2018
DUBLIN, Ireland and CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today [...]
Aleafia Health to Launch Global Cannabis Education Platform with D2L
14/11/2018
Platform to Provide Cannabis Education Courses TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“ Aleafia ”) has entered into a global agreement with D2L ( [...]
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder
14/11/2018
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Trillium Therapeutics Reports Third Quarter 2018 Financial and Operating Results
14/11/2018
Positive clinical update on the intratumoral trial of TTI-621, a CD47 immune checkpoint inhibitor, presented at the 2018 EORTC CLTF meeting Positive clinical update on the intravenous trial of TTI-621 presented at the [...]
Evogene Reports Third Quarter 2018 Financial Results
14/11/2018
REHOVOT, Israel, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science [...]
Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update
14/11/2018
Third quarter revenue increased to $18.4 million compared to $14.0 million in 3Q 2017 Positive recommendation by DSMB upon second interim analysis for Oraxol Phase III program KX2-391 Phase III pivotal studies achieved [...]
MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) is pleased to announce that its wholly owned subsidiary MediPharm Labs Inc. (“ MediPharm ”) has [...]
Canopy Rivers to Report Second Quarter Fiscal 2019 Financial Results
14/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ”) (TSXV: RIV) will report its second quarter fiscal 2019 financial [...]
Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia
14/11/2018
MALVERN, Pa., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Novan Phase 2 Molluscum Contagiosum Trial Achieves Statistical Significance in Preliminary Top Line Results
14/11/2018
Higher rates of complete clearance of all molluscum lesions at Week 12 for the two highest doses, SB206 8% and 12% twice-daily, more than double the rate observed in the vehicle group Clear treatment effect observed as [...]
Opthea Completes Patient Recruitment Ahead of Schedule in Phase 2b Wet AMD Clinical Trial
14/11/2018
MELBOURNE, Australia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, today announced that recruitment [...]
Terveystalo Plc: Financial calendar and AGM in 2019
14/11/2018
Terveystalo Plc Stock Exchange Release 14 November 2018 at 09:05 a.m. EET In 2019, Terveystalo Plc will publish financial reports as follows: Financial Statements Bulletin 2018 on Thursday, February 14, 2019 Annual [...]
Customer evaluation of CADScor®System compares favorably against existing methods
14/11/2018
Interim Report, January - September 2018 Malmö, November 14, 2018 Customer evaluation of CADScor®System compares favorably against existing methods "During the quarter we proudly reported that Kristianstad Central [...]
Terveystalo Group Interim Report 1 January - 30 September 2018
14/11/2018
Terveystalo Plc. Interim report 14 November 2018 at 9:00 a.m. EET Strong earnings trend continued July-September 2018 in brief Revenue increased by 3.2 percent year-on-year to EUR 160.3 million (155.4) Adjusted* EBITDA [...]

Pages